These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26590612)

  • 1. A proposal for a novel rationale for critical effect size in dose-response analysis based on a multi-endpoint in vivo study with methyl methanesulfonate.
    Zeller A; Tang L; Dertinger SD; Funk J; Duran-Pacheco G; Guérard M
    Mutagenesis; 2016 May; 31(3):239-53. PubMed ID: 26590612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An appraisal of critical effect sizes for the benchmark dose approach to assess dose-response relationships in genetic toxicology.
    Zeller A; Duran-Pacheco G; Guérard M
    Arch Toxicol; 2017 Dec; 91(12):3799-3807. PubMed ID: 28799093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-Response for Multiple Biomarkers of Exposure and Genotoxic Effect Following Repeated Treatment of Rats with the Alkylating Agents, MMS and MNU.
    Ji Z; LeBaron MJ; Schisler MR; Zhang F; Bartels MJ; Gollapudi BB; Pottenger LH
    Mutagenesis; 2016 May; 31(3):297-308. PubMed ID: 26040483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of potential thresholds for N-ethyl-N-nitrosourea and ethyl methanesulfonate based on a multi-endpoint genotoxicity assessment platform in rats.
    Zhu X; Huo J; Zeng Z; Liu Y; Li R; Chen Y; Zhang L; Chen J
    Environ Sci Pollut Res Int; 2022 Dec; 29(56):85128-85142. PubMed ID: 35793016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Interpretation of Genetic Toxicity Dose-Response Data for Risk Assessment and Regulatory Decision-Making: Current Status and Emerging Priorities.
    White PA; Long AS; Johnson GE
    Environ Mol Mutagen; 2020 Jan; 61(1):66-83. PubMed ID: 31794061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological significance of DNA adducts investigated by simultaneous analysis of different endpoints of genotoxicity in L5178Y mouse lymphoma cells treated with methyl methanesulfonate.
    Brink A; Schulz B; Stopper H; Lutz WK
    Mutat Res; 2007 Dec; 625(1-2):94-101. PubMed ID: 17586535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response and operational thresholds/NOAELs for in vitro mutagenic effects from DNA-reactive mutagens, MMS and MNU.
    Pottenger LH; Schisler MR; Zhang F; Bartels MJ; Fontaine DD; McFadden LG; Bhaskar Gollapudi B
    Mutat Res; 2009 Aug; 678(2):138-47. PubMed ID: 19616119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs).
    MacGregor JT; Frötschl R; White PA; Crump KS; Eastmond DA; Fukushima S; Guérard M; Hayashi M; Soeteman-Hernández LG; Kasamatsu T; Levy DD; Morita T; Müller L; Schoeny R; Schuler MJ; Thybaud V; Johnson GE
    Mutat Res Genet Toxicol Environ Mutagen; 2015 May; 783():55-65. PubMed ID: 25953400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of the dose-response of alkylating agents in DNA repair proficient and deficient ames tester strains.
    Tang L; Guérard M; Zeller A
    Environ Mol Mutagen; 2014 Jan; 55(1):15-23. PubMed ID: 24273186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxicity studies of organically grown broccoli (Brassica oleracea var. italica) and its interactions with urethane, methyl methanesulfonate and 4-nitroquinoline-1-oxide genotoxicity in the wing spot test of Drosophila melanogaster.
    Heres-Pulido ME; Dueñas-García I; Castañeda-Partida L; Santos-Cruz LF; Vega-Contreras V; Rebollar-Vega R; Gómez-Luna JC; Durán-Díaz A
    Food Chem Toxicol; 2010 Jan; 48(1):120-8. PubMed ID: 19786056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in vitro and in vivo clastogenic potency based on benchmark dose analysis of flow cytometric micronucleus data.
    Bemis JC; Wills JW; Bryce SM; Torous DK; Dertinger SD; Slob W
    Mutagenesis; 2016 May; 31(3):277-85. PubMed ID: 26049158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
    Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
    Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Drosophila melanogaster as an in vivo model for genotoxicity assessment using modified alkaline Comet assay.
    Siddique HR; Chowdhuri DK; Saxena DK; Dhawan A
    Mutagenesis; 2005 Jul; 20(4):285-90. PubMed ID: 15899934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing BMD-derived genotoxic potency estimations across variants of the transgenic rodent gene mutation assay.
    Wills JW; Johnson GE; Battaion HL; Slob W; White PA
    Environ Mol Mutagen; 2017 Dec; 58(9):632-643. PubMed ID: 28945287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative approaches for assessing dose-response relationships in genetic toxicology studies.
    Gollapudi BB; Johnson GE; Hernandez LG; Pottenger LH; Dearfield KL; Jeffrey AM; Julien E; Kim JH; Lovell DP; Macgregor JT; Moore MM; van Benthem J; White PA; Zeiger E; Thybaud V
    Environ Mol Mutagen; 2013 Jan; 54(1):8-18. PubMed ID: 22987251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of N-ethyl-N-nitrosourea, N-methyl-N-nitrosourea, methyl methanesulfonate and ethyl methanesulfonate in the developing Syrian hamster fetus.
    Donovan P; Smith G
    Mutat Res; 2010 Jun; 699(1-2):55-7. PubMed ID: 20363361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk.
    MacGregor JT; Frötschl R; White PA; Crump KS; Eastmond DA; Fukushima S; Guérard M; Hayashi M; Soeteman-Hernández LG; Johnson GE; Kasamatsu T; Levy DD; Morita T; Müller L; Schoeny R; Schuler MJ; Thybaud V
    Mutat Res Genet Toxicol Environ Mutagen; 2015 May; 783():66-78. PubMed ID: 25953401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empirical analysis of BMD metrics in genetic toxicology part I: in vitro analyses to provide robust potency rankings and support MOA determinations.
    Wills JW; Johnson GE; Doak SH; Soeteman-Hernández LG; Slob W; White PA
    Mutagenesis; 2016 May; 31(3):255-63. PubMed ID: 26687511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies in genotoxicology: Acceptance of innovative scientific methods in a regulatory context and from an industrial perspective.
    Steiblen G; Benthem JV; Johnson G
    Mutat Res Genet Toxicol Environ Mutagen; 2020 May; 853():503171. PubMed ID: 32522346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.